CAS 1240516-71-5

Fórmula: C24H25ClN4O5S2

InChI: InChI=1S/C24H25ClN4O5S2/c1-24(2,31)23(30)26-13-15-6-4-7-16(12-15)14-29-17-8-5-9-18(34-3)21(17)22(27-29)28-36(32,33)20-11-10-19(25)35-20/h4-12,31H,13-14H2,1-3H3,(H,26,30)(H,27,28)

Clave InChI: YTEVTHHGQMUPHC-UHFFFAOYSA-N

SMILES: CC(C)(C(=O)NCC1=CC(=CC=C1)CN2C3=C(C(=CC=C3)OC)C(=N2)NS(=O)(=O)C4=CC=C(S4)Cl)O

GSK2239633A

CAS: 1240516-71-5

GSK2239633A

Fórmula: C₂₄H₂₅ClN₄O₅S₂

Pureza: 99.5%

Peso molecular: 549.06

Ref: 54-BUP05286

N-[[3-[[3-[[(5-chloro-2-thienyl)sulfonyl]amino]-4-methoxy-1H-indazol-1-yl]methyl]phenyl]methyl]-2-hydroxy-2-methylpropanamide

CAS: 1240516-71-5

Fórmula: C₂₄H₂₅ClN₄O₅S₂

Pureza: 98%

Forma y color: Solid

Peso molecular: 549.0621

Ref: IN-DA01EOL0

GSK2239633A

CAS: 1240516-71-5

GSK2239633A is a potent and selective inhibitor of IL-5 receptor alpha. It has been shown to inhibit the production of inflammatory cytokines in bronchial explants from asthma patients, as well as inhibiting chemotaxis and mucosal inflammation. GSK2239633A inhibits the synthesis of IL-5 by binding to the cytoplasmic domain of the IL-5 receptor alpha. This inhibition leads to reduced IL-5 production and subsequently a decrease in eosinophil recruitment into tissue. GSK2239633A also binds to other chemokine receptors, including CCR4 and CCR8, which may contribute to its anti-inflammatory effects.

Fórmula: C₂₄H₂₅ClN₄O₅S₂

Pureza: Min. 95%

Peso molecular: 549.06 g/mol

Ref: 3D-QZB51671

GSK2239633A

CAS: 1240516-71-5

GSK2239633A is an allosteric antagonist of CC-chemokine receptor 4 (CCR4) with a pIC50 of 7.96 for the binding of [125I]-TARC to human CCR4.

Fórmula: C₂₄H₂₅ClN₄O₅S₂

Pureza: 99.82%

Forma y color: White Solid

Peso molecular: 549.062

Ref: TM-T11481